India MeitY Advisory Dispute: Reports of OpenAI/Anthropic Pause, Then Government Denial
View original source →A disputed advisory emerged in India this week: ThePrint reported on July 13, 2026, that India's Ministry of Electronics and Information Technology had directed government ministries to pause using OpenAI and Anthropic AI models for cybersecurity functions — citing data sovereignty concerns. The government issued a formal denial within 24 hours.
Key Points:
• ThePrint reported July 13 that a MeitY-affiliated body had told ministries to hold off on deploying OpenAI and Anthropic cybersecurity AI models — citing concerns about data sovereignty and the government's push for indigenous AI through the IndiaAI Mission.
• The Press Information Bureau (PIB) issued a formal fact-check denial on July 14, stating that MeitY had not issued any direction or advisory asking ministries to stop using OpenAI or Anthropic models.
• The reports emerged in the context of India's active IndiaAI Mission — a government initiative funding domestic compute capacity, datasets, and indigenous foundation models.
• Multiple independent news outlets reported on the same information before the government denial was issued, lending the original report additional credibility despite the denial.
Whether or not a formal advisory existed, the episode illustrates a pattern emerging across major economies: AI sovereignty — the principle that critical government functions should use domestically developed or controlled AI — is becoming operational policy, even when not formally declared.
For AI companies with government customers internationally, the India situation previews the environment they will face in an increasing number of countries. Even informal guidance can create market access uncertainty that affects enterprise AI procurement decisions.
Why It Matters: AI sovereignty policies are fragmenting the international AI market. Organizations providing AI services to government customers should map sovereignty policies by country as a distinct regulatory risk.